The U.S. Supreme Court on Monday denied American Commercial Lines LLC's bid for review of a Fifth Circuit decision that left in place a $20 million liability judgment against the company stemming from an oil spill caused by a barge collision on the Mississippi River.
Television personality Dr. Oz agreed to a $5.25 million settlement in California federal court Friday to resolve allegations that his show misrepresented the effectiveness of weight-loss supplements.
Despite decades of industrywide initiatives, movement up the ladder has stagnated for minority lawyers. Here, five industry success stories tell Law360 about the paths they took and what needs to change in BigLaw.
The New Jersey Supreme Court declined to review a state appellate decision upholding a jury’s unanimous finding that a bicyclist who received quadriplegic injuries was wearing a non-defective helmet, according to a Friday filing.
A New York federal judge certified a class of Fiat Chrysler investors in a stock-drop suit alleging the automaker lied about using emissions-cheating devices in vehicles in an effort to inflate the company's stock price.
National Casualty Co. has told a California federal court that it shouldn't have to cover the National Strength and Conditioning Association in two false advertising suits brought by CrossFit Inc. over a study that portrayed CrossFit's exercise regiment as unsafe, after the NSCA was hit with nearly $500,000 in sanctions.
A New Jersey federal judge has placed on hold two class actions over Samsung Electronics America Inc.’s allegedly defective washing machines while a judicial panel determines if they should be folded into multidistrict litigation over the same issue.
Pharmaceutical giant Bayer AG knocked down a customer's claims that she developed gallbladder disease after using the company's Yaz and Yasmin birth control pills, after a New Jersey state appeals court on Monday found that shortcomings in her expert report justified nixing her bid to revive the litigation.
Google LLC and Huawei Device USA Inc. urged a California federal judge on Monday to reject efforts to jump-start discovery in a suit accusing the tech giants of manufacturing defective Google Nexus 6P smartphones, calling the proposed class' new complaint "overreaching and unwieldy."
A Virginia federal judge overseeing multidistrict litigation involving Lumber Liquidators’ alleged false statements that its laminate wood flooring complied with California Air Resource Board’s formaldehyde emissions limits preliminarily approved a $36 million agreement to end the litigation.
Despite the proliferation of diversity committees and inclusion initiatives, corporate law firms remain overwhelmingly white and male, especially at leadership levels. Here, minority attorneys discuss their reasons for leaving a large firm.
The often-informal processes for deciding matters like compensation at law firms can create, as one expert put it, a “petri dish” for the effects of unconscious bias. Here’s how some firms are looking to shake up the system.
While U.S. law firms have long vowed to make their ranks more diverse and inclusive, the industry has long failed to deliver on those promises. Here are the firms making some headway, according to this year’s Diversity Snapshot.
Efforts to increase diversity have again yielded few meaningful changes in law firm demographics, according to Law360’s annual headcount survey, even as law schools continue to enroll students of color in increasing numbers.
For years law firms have had programs aimed at increasing attorney diversity, but nothing is working. On this week’s Pro Say podcast we take a look at our latest survey of diversity at law firms, and unpack what experts say are the things that could actually move the needle on this issue.
Fitbit Inc. abused its own arbitration clause to avoid ever facing claims from consumers about problems with its heart-monitoring watches, the consumers’ attorneys told a California federal judge Friday, saying the company refused to participate in the arbitration it had requested for two years.
The Federal Trade Commission asked the Eleventh Circuit to uphold $40 million in sanctions against Hi-Tech Pharmaceuticals Inc. and two executives for allegedly violating an injunction barring them from making unsubstantiated weight-loss claims, saying they knew they were flouting the order.
Walgreens helped spread unneeded opioids throughout Kentucky as both pharmacy chain and distributor, the state's attorney general said in a lawsuit filed Thursday, allegedly cultivating a public health nightmare that has killed Kentuckians, defrauded Medicaid and spurred an armed-robbery epidemic.
The U.S. Environmental Protection Agency can’t nix allegations it failed to investigate the effect of more than 2,000 pesticide products on endangered species, a California federal judge said Friday, but he added that, down the line, environmentalists need to do a “much better job” of linking animals to the chemicals purportedly threatening them.
A Virginia federal judge rejected a request by a Korean tire company to seal certain trial records in the wake of a $38 million negligence verdict against the manufacturer, saying in a ruling Thursday that the public’s right to access the records trumped its confidentiality concerns.
Despite the partiality some courts have shown to live video testimony, it provides no advantages — and several disadvantages — over the tried-and-true method of videotaped depositions, say attorneys with Skadden Arps Slate Meagher & Flom LLP.
Beginning in May, certain restaurants, grocers and other food establishments nationwide were required to comply with the U.S. Food and Drug Administration’s menu labeling rules. While some businesses have argued that the rules are overly broad, it appears the Trump administration has no plans to intervene, say Robert Milligan and Joshua Salinas of Seyfarth Shaw LLP.
"Uncivil Warriors: The Lawyers' Civil War," by Peter Hoffer, is a new book about the involvement of lawyers on both sides in the American Civil War. The discussion is enlightening and often fascinating, but falls short in several key areas, says Federal Circuit Judge Evan Wallach.
Recently signed into law by the president, the federal Right to Try Act creates a framework for patients to access investigational new drug products. But it comes in the wake of a majority of states passing their own "right to try" laws, creating the potential for a conflict between state laws, the U.S. Food and Drug Administration’s expanded access regulations and federal statutes, say attorneys with Morgan Lewis & Bockius LLP.
Connecting with potential prospects is now more challenging due to the EU General Data Protection Regulation, meaning that law firm microsites, blogs and social media will become more valuable than ever. The firms that deploy them strategically will increase their relative visibility and accelerate the rebuilding of their opt-in distribution lists, says Stephan Roussan of ICVM Group.
The judge in the national opioid multidistrict litigation recently ordered lawyers to disclose whether their cases are financed by third parties. This has drawn attention to courts’ responsibility to address problems surrounding third-party litigation funding, but a uniform funding disclosure requirement would be more effective, says Alex Dahl of Strategic Policy Counsel PLLC.
The emerging contaminants known as perfluoroalkyl or polyfluoroalkyl substances have captured the attention of regulators and courts across the country. In the final part of this series, Jeffrey Dintzer and Nathaniel Johnson of Alston & Bird LLP discuss how to prepare for the growing risk that PFAS regulations and litigation can pose.
The U.S. Food and Drug Administration recently launched an initiative to reduce the use of e-cigarettes and related products by young people. While it is not clear how extensively the FDA will try to restrict electronic nicotine delivery systems and e-liquids, forthcoming proposals may be substantial, say Azim Chowdhury and Benjamin Wolf of Keller & Heckman LLP.
The U.S. Environmental Protection Agency recently held its National Leadership Summit with the goal of “taking action” on the emerging contaminants known as perfluoroalkyl or polyfluoroalkyl substances. In part one of this two-part series, Jeffrey Dintzer and Nathaniel Johnson of Alston & Bird LLP discuss the possible legal consequences for businesses that manufacture, sell or consume PFAS products.
As the Judicial Panel on Multidistrict Litigation heads to Chicago for its May 31 hearing session, Alan Rothman of Arnold & Porter observes the panel’s golden anniversary with a retrospective look at its origins in the enactment of the MDL statute in April 1968, and reviews its most recent hearing session held in Atlanta on March 29.